|
humans |
28 |
|
adult |
26 |
|
female |
25 |
|
male |
24 |
|
hong kong - epidemiology |
23 |
|
middle aged |
23 |
|
aged |
20 |
|
cost-effectiveness |
20 |
|
hong kong |
20 |
|
chinese |
15 |
|
evaluation |
14 |
|
mortality |
14 |
|
prevalence |
13 |
|
questionnaires |
13 |
|
regression analysis |
13 |
|
risk factors |
13 |
|
first episode |
12 |
|
schizophrenia |
12 |
|
cross-sectional studies |
11 |
|
diabetes mellitus |
11 |
|
screening |
11 |
|
logistic models |
10 |
|
blood glucose - metabolism |
9 |
|
blood pressure |
9 |
|
diabetic retinopathy |
9 |
|
food habits |
9 |
|
glucose tolerance test |
9 |
|
medical sciences |
9 |
|
proportional hazards models |
9 |
|
socioeconomic factors |
9 |
|
tobacco smoke pollution - statistics & numerical data |
9 |
|
young adult |
9 |
|
adolescent |
8 |
|
cardiovascular diseases - etiology |
8 |
|
china - ethnology |
8 |
|
cohort studies |
8 |
|
educational status |
8 |
|
fasting |
8 |
|
lipids |
8 |
|
metabolic syndrome x - complications |
8 |
|
normoglycemia |
8 |
|
obesity |
8 |
|
obesity - complications |
8 |
|
reference values |
8 |
|
smoking |
8 |
|
acute bed day use |
7 |
|
case-control studies |
7 |
|
child |
7 |
|
child, preschool |
7 |
|
colorectal neoplasm |
7 |
|
cost-of-illness |
7 |
|
diet |
7 |
|
direct medical cost |
7 |
|
family characteristics |
7 |
|
fruit |
7 |
|
health care service provider |
7 |
|
health services |
7 |
|
hospitals - utilization |
7 |
|
infant |
7 |
|
last years of life |
7 |
|
length of stay - statistics & numerical data |
7 |
|
multidisciplinary |
7 |
|
primary care |
7 |
|
quality of life |
7 |
|
registries |
7 |
|
restaurants - legislation & jurisprudence |
7 |
|
service utilization |
7 |
|
smoking - adverse effects |
7 |
|
smoking - epidemiology |
7 |
|
smoking - legislation & jurisprudence - prevention & control |
7 |
|
terminally ill |
7 |
|
vegetables |
7 |
|
absenteeism |
6 |
|
age factors |
6 |
|
cause of death |
6 |
|
china |
6 |
|
china - epidemiology |
6 |
|
cost-benefit analysis |
6 |
|
covid-19 |
6 |
|
elderly |
6 |
|
environmental stressors |
6 |
|
epidemiological study |
6 |
|
hospitalization - statistics & numerical data |
6 |
|
infant, newborn |
6 |
|
infection - epidemiology |
6 |
|
major depressive episode |
6 |
|
maternal age |
6 |
|
metabolic syndrome |
6 |
|
metabolic syndrome x - complications - epidemiology - mortality |
6 |
|
passive smoking |
6 |
|
respiration-disorders-etiology |
6 |
|
risk assessment |
6 |
|
risk stratification |
6 |
|
sex distribution |
6 |
|
smoking-adverse-effects |
6 |
|
social unrest |
6 |
|
stressful life events |
6 |
|
tobacco-smoke-pollution-adverse-effects |
6 |
|
vascular diseases - etiology - mortality |
6 |
|
youth mental health |
6 |
|
abdominal fat - physiology |
5 |
|
adenocarcinoma - drug therapy - economics |
5 |
|
age-related macular degeneration |
5 |
|
aged, 80 and over |
5 |
|
air pollutants, occupational - analysis - toxicity |
5 |
|
air pollution, indoor - adverse effects - analysis |
5 |
|
alcohol drinking - adverse effects - mortality |
5 |
|
antineoplastic combined chemotherapy protocols - administration and dosage - economics - therapeutic use |
5 |
|
atherosclerosis - epidemiology - metabolism - prevention & control |
5 |
|
blood glucose - analysis |
5 |
|
blood pressure - physiology |
5 |
|
body composition - physiology |
5 |
|
body mass index |
5 |
|
buddy |
5 |
|
capecitabine |
5 |
|
cardiovascular complications |
5 |
|
cardiovascular diseases - blood - epidemiology |
5 |
|
cardiovascular diseases - epidemiology - etiology - metabolism |
5 |
|
case-control |
5 |
|
case-control study |
5 |
|
colorectal neoplasms - drug therapy - economics |
5 |
|
coronary artery disease |
5 |
|
cost of illness |
5 |
|
costing analysis |
5 |
|
cotinine - urine |
5 |
|
diet - adverse effects - statistics & numerical data |
5 |
|
dietary fats |
5 |
|
dietary fiber - therapeutic use |
5 |
|
down syndrome - epidemiology |
5 |
|
dyslipidemias - physiopathology |
5 |
|
environmental monitoring - methods |
5 |
|
epidemiologic methods |
5 |
|
exercise |
5 |
|
eye diseases - epidemiology |
5 |
|
fasting - blood |
5 |
|
fish |
5 |
|
fish oils |
5 |
|
folinic acid |
5 |
|
food handling |
5 |
|
forced expiratory volume - physiology |
5 |
|
fruits |
5 |
|
glucose intolerance - blood - etiology |
5 |
|
guidelines as topic |
5 |
|
health care costs - statistics and numerical data |
5 |
|
health-care-costs |
5 |
|
healthcare costs |
5 |
|
hospital authority |
5 |
|
hyperglycemia - physiopathology |
5 |
|
hypertension - physiopathology |
5 |
|
insurance, health, reimbursement - economics |
5 |
|
intraocular pressure |
5 |
|
legumes |
5 |
|
linear models |
5 |
|
lung - physiology |
5 |
|
meat |
5 |
|
mental disorders - epidemiology |
5 |
|
microvascular complications |
5 |
|
mortality - trends |
5 |
|
multivariate analysis |
5 |
|
obesity - physiopathology |
5 |
|
occupational exposure - adverse effects - analysis - legislation & jurisprudence |
5 |
|
odds ratio |
5 |
|
older adults |
5 |
|
oxaliplatin |
5 |
|
particulate matter - analysis - toxicity |
5 |
|
pedometer |
5 |
|
physical activity |
5 |
|
police |
5 |
|
prospective studies |
5 |
|
proxy |
5 |
|
public health and safety |
5 |
|
refraction, ocular - physiology |
5 |
|
reproducibility of results |
5 |
|
respiratory tract diseases - epidemiology - etiology |
5 |
|
seafood |
5 |
|
sex factors |
5 |
|
smoking - adverse effects - mortality |
5 |
|
smoking-economics |
5 |
|
societal perspective |
5 |
|
soy |
5 |
|
soy foods |
5 |
|
soy foods - utilization |
5 |
|
synergy |
5 |
|
tea |
5 |
|
tobacco |
5 |
|
tobacco smoke pollution - adverse effects - analysis - legislation & jurisprudence |
5 |
|
tobacco smoke pollution - adverse effects - statistics & numerical data |
5 |
|
tobacco-smoke-pollution-economics |
5 |
|
tobacco-use-disorder-economics |
5 |
|
trials |
5 |
|
vascular diseases - epidemiology - metabolism - prevention & control |
5 |
|
visual acuity - physiology |
5 |
|
visually impaired persons - statistics & numerical data |
5 |
|
vital capacity - physiology |
5 |
|
vitamins - therapeutic use |
5 |
|
waist-hip ratio |
5 |
|
water-electrolyte balance - physiology |
5 |
|
workplace |
5 |
|
adolescent behavior - psychology |
4 |
|
air pollutants, occupational - analysis - poisoning |
4 |
|
air pollution |
4 |
|
air pollution - adverse effects |
4 |
|
air pollution - adverse effects - analysis - economics |
4 |
|
air quality guidelines |
4 |
|
air quality objectives |
4 |
|
alcohol drinking - psychology |
4 |
|
anthropometry |
4 |
|
attitude to health |
4 |
|
cost‐effectiveness |
4 |
|
decision analysis |
4 |
|
doctor shopping |
4 |
|
electronic cigarette |
4 |
|
epidemiology |
4 |
|
eye diseases - diagnosis |
4 |
|
eye disorders |
4 |
|
food services - legislation and jurisprudence - statistics and numerical data |
4 |
|
glaucoma |
4 |
|
great britain - epidemiology |
4 |
|
health care costs |
4 |
|
health policy - legislation & jurisprudence |
4 |
|
health services research |
4 |
|
hospitalization |
4 |
|
hospitalization - economics - statistics & numerical data |
4 |
|
hypertension - epidemiology |
4 |
|
incidence |
4 |
|
industry |
4 |
|
lung cancer |
4 |
|
marine vessel emission |
4 |
|
marpol convention |
4 |
|
nitrogen dioxide - analysis |
4 |
|
nonattendance |
4 |
|
ozone - analysis |
4 |
|
particulate matter - analysis |
4 |
|
perception |
4 |
|
plants, toxic |
4 |
|
public opinion |
4 |
|
pulmonary disease, chronic obstructive - epidemiology - mortality |
4 |
|
pulmonary disease, chronic obstructive - etiology |
4 |
|
research support |
4 |
|
respiratory tract diseases - economics - etiology - mortality |
4 |
|
risk assessment and management |
4 |
|
self-management education |
4 |
|
smoking - epidemiology - psychology |
4 |
|
social responsibility |
4 |
|
substance-related disorders - psychology |
4 |
|
sulfur dioxide |
4 |
|
sulfur dioxide - analysis |
4 |
|
tobacco smoke pollution - adverse effects |
4 |
|
tobacco smoke pollution - adverse effects - analysis |
4 |
|
tobacco smoke pollution - legislation & jurisprudence - prevention & control |
4 |
|
type 2 diabetes |
4 |
|
type 2 diabetes mellitus |
4 |
|
waiting time |
4 |
|
willingness to pay |
4 |
|
willingness-to-pay |
4 |
|
world health organization |
4 |
|
activities of daily living - psychology |
3 |
|
age distribution |
3 |
|
age-period-cohort |
3 |
|
ageing |
3 |
|
aging - physiology |
3 |
|
alcohol drinking - epidemiology |
3 |
|
asia |
3 |
|
asian continental ancestry group - statistics & numerical data |
3 |
|
attitude of health personnel |
3 |
|
attitude to computers |
3 |
|
bayesian methods |
3 |
|
c-reactive protein - metabolism |
3 |
|
cardiovascular diseases |
3 |
|
cardiovascular diseases - epidemiology - ethnology |
3 |
|
catchment area (health) |
3 |
|
catering workers |
3 |
|
cervical cancer |
3 |
|
cervical intraepithelial neoplasia - diagnosis - epidemiology - prevention & control |
3 |
|
cervical screening |
3 |
|
cholesterol, hdl - blood |
3 |
|
cognition disorders - epidemiology - psychology |
3 |
|
commerce |
3 |
|
computer systems |
3 |
|
consultants |
3 |
|
delivery of health care |
3 |
|
depression - epidemiology - psychology |
3 |
|
diabetes complications |
3 |
|
diabetes mellitus - epidemiology - psychology |
3 |
|
discrete choice experiment |
3 |
|
effectiveness |
3 |
|
efficiency |
3 |
|
efficiency, organizational |
3 |
|
evaluation studies as topic |
3 |
|
financing, personal |
3 |
|
geriatric assessment - statistics & numerical data |
3 |
|
glucose |
3 |
|
great britain |
3 |
|
health care delivery |
3 |
|
health care reform |
3 |
|
health promotion |
3 |
|
heart disease |
3 |
|
hospitals, special |
3 |
|
hpv |
3 |
|
hypertension |
3 |
|
marriage |
3 |
|
mass screening |
3 |
|
maximum likelihood estimation |
3 |
|
medical records |
3 |
|
medical records systems |
3 |
|
medical records systems, computerized - standards |
3 |
|
medical records, problem-oriented |
3 |
|
metabolic syndrome x - epidemiology |
3 |
|
models, econometric |
3 |
|
models, theoretical |
3 |
|
need and demand |
3 |
|
obesity - epidemiology |
3 |
|
occupational exposure - adverse effects - economics |
3 |
|
office visits - economics - utilization |
3 |
|
patient acceptance of health care |
3 |
|
patient care |
3 |
|
physicians |
3 |
|
private sector - economics - utilization |
3 |
|
problem-oriented |
3 |
|
public sector - economics - utilization |
3 |
|
quality of health care |
3 |
|
referral and consultation |
3 |
|
risk |
3 |
|
secondhand smoke |
3 |
|
smoking - legislation & jurisprudence |
3 |
|
snoring |
3 |
|
snoring - epidemiology - ethnology |
3 |
|
time factors |
3 |
|
tobacco smoke pollution - legislation & jurisprudence |
3 |
|
urinary cotinine |
3 |
|
uterine cervical neoplasms - diagnosis - epidemiology - prevention & control |
3 |
|
vaccination |
3 |
|
value of life - economics |
3 |
|
vascular disease |
3 |
|
vascular diseases - blood - epidemiology |
3 |
|
waiting lists |
3 |
|
workload |
3 |
|
aftercare - standards |
2 |
|
aged -- hong kong |
2 |
|
ambulatory care - utilization |
2 |
|
angioplasty, balloon, coronary - economics - rehabilitation |
2 |
|
antihypertensive agents - economics - therapeutic use |
2 |
|
antithyroid agents - administration & dosage - therapeutic use |
2 |
|
asian continental ancestry group |
2 |
|
asian continental ancestry group - statistics and numerical data |
2 |
|
asthma - complications |
2 |
|
beside care |
2 |
|
body weight |
2 |
|
capitation |
2 |
|
cardiovascular disease |
2 |
|
cardiovascular diseases - prevention & control |
2 |
|
cerebrovascular disorders -- economics -- hong kong |
2 |
|
cerebrovascular disorders -- hong kong |
2 |
|
chronic disease - economics |
2 |
|
clinical protocols - standards |
2 |
|
combined modality therapy |
2 |
|
community networks - organization & administration |
2 |
|
consumer satisfaction |
2 |
|
continuity of patient care - economics |
2 |
|
contract services - organization & administration |
2 |
|
cost-effectiveness analysis |
2 |
|
costs and cost analysis |
2 |
|
data collection |
2 |
|
data collection - instrumentation |
2 |
|
delivery of health care - organization & administration |
2 |
|
dementia -- china -- hong kong |
2 |
|
dementia -- diagnosis |
2 |
|
dementia -- patients -- care -- china -- hong kong |
2 |
|
demography |
2 |
|
diabetes mellitus - economics - therapy |
2 |
|
diabetes mellitus - therapy |
2 |
|
diabetes mellitus, type 2 - blood - epidemiology |
2 |
|
diabetic angiopathies - epidemiology |
2 |
|
diabetic retinopathy screening |
2 |
|
disease outbreaks |
2 |
|
economics, medical |
2 |
|
evaluation of hand-held computers |
2 |
|
exercise therapy |
2 |
|
exercise therapy - economics |
2 |
|
family practice - economics |
2 |
|
feasibility studies |
2 |
|
financial incentive |
2 |
|
financial incentives |
2 |
|
gender |
2 |
|
gp hospital relationship |
2 |
|
harm reduction |
2 |
|
health benefits |
2 |
|
health care costs - classification - statistics & numerical data |
2 |
|
health status indicators |
2 |
|
hepatitis b virus |
2 |
|
home care services |
2 |
|
house calls |
2 |
|
hypercholesterolemia - drug therapy - economics - prevention & control |
2 |
|
hypertension - drug therapy |
2 |
|
hypertension - economics - therapy |
2 |
|
hyperthyroidism - drug therapy - epidemiology |
2 |
|
illness |
2 |
|
immunization programs - economics |
2 |
|
influenza |
2 |
|
influenza vaccines - administration & dosage - economics |
2 |
|
influenza vaccines - economics - immunology |
2 |
|
influenza, human - economics - epidemiology - prevention & control |
2 |
|
influenza/epidemiology |
2 |
|
influenza/prevention & control |
2 |
|
intention to quit |
2 |
|
interprofessional relations |
2 |
|
interviews as topic |
2 |
|
iodine radioisotopes - administration & dosage - therapeutic use |
2 |
|
life expectancy |
2 |
|
life style |
2 |
|
long term care |
2 |
|
long-term care - organization & administration |
2 |
|
lung neoplasms - etiology - mortality |
2 |
|
lungs -- diseases, obstructive |
2 |
|
managed care |
2 |
|
managed care programs - organization & administration |
2 |
|
mass screening - organization & administration |
2 |
|
medicine & public health |
2 |
|
metabolic syndrome x - etiology |
2 |
|
microcomputers |
2 |
|
middle cerebral artery stenosis |
2 |
|
myocardial infarction - blood - diagnosis - drug therapy |
2 |
|
myocardial infarction - economics - psychology - therapy |
2 |
|
myocardial ischemia |
2 |
|
nicotine - administration & dosage |
2 |
|
nursing |
2 |
|
nursing care |
2 |
|
obstructive lung disease |
2 |
|
older people -- care -- china -- hong kong |
2 |
|
ophthalmology |
2 |
|
outcome and process assessment (health care) - economics |
2 |
|
outcome assessment (health care) |
2 |
|
patient care planning |
2 |
|
patient care team |
2 |
|
patient education as topic - economics |
2 |
|
patient satisfaction |
2 |
|
peripheral vascular disease |
2 |
|
physician's practice patterns - statistics & numerical data |
2 |
|
point-of-care systems |
2 |
|
population surveillance |
2 |
|
pravastatin - economics - therapeutic use |
2 |
|
preference-based measure |
2 |
|
primary health care - economics |
2 |
|
primary prevention - economics |
2 |
|
public policy |
2 |
|
pulmonary disease, chronic obstructive - complications |
2 |
|
quality-adjusted life years |
2 |
|
radiation dosage |
2 |
|
recurrence |
2 |
|
rehabilitation |
2 |
|
respiratory diseases in old age -- china -- hong kong |
2 |
|
retinopathy |
2 |
|
risk-taking |
2 |
|
satisfaction |
2 |
|
sf-6d |
2 |
|
shared care |
2 |
|
smoking - adverse effects - epidemiology |
2 |
|
smoking cessation |
2 |
|
social work with older people -- china -- hong kong |
2 |
|
sodium |
2 |
|
specialization |
2 |
|
standard gamble |
2 |
|
student dropouts |
2 |
|
successful quitting |
2 |
|
sweden |
2 |
|
travel |
2 |
|
treatment refusal |
2 |
|
united states |
2 |
|
uptake |
2 |
|
uterine cervical neoplasms - mortality |
2 |
|
vaccination - economics |
2 |
|
vaccine |
2 |
|
validity |
2 |
|
value of life |
2 |
|
vascular diseases - etiology |
2 |
|
waist circumference |
2 |
|
weight |
2 |
|
aging |
1 |
|
air pollution - adverse effects - economics |
1 |
|
alcohol drinking - economics - epidemiology |
1 |
|
alcohol drinking behavior |
1 |
|
alcoholic beverages - economics |
1 |
|
alcoholism - economics - epidemiology |
1 |
|
cba |
1 |
|
conjoint analysis |
1 |
|
coronary disease - mortality - therapy |
1 |
|
cost |
1 |
|
cost of treatment |
1 |
|
delivery of health care - methods |
1 |
|
econometrics |
1 |
|
economic evaluation |
1 |
|
end-of-life care |
1 |
|
enteric-coated nsaid |
1 |
|
follow-up studies |
1 |
|
gastrointestinal side effects |
1 |
|
general practice |
1 |
|
general practitioner |
1 |
|
health policy |
1 |
|
hypertension - therapy |
1 |
|
khon kaen |
1 |
|
longitudinal studies |
1 |
|
models, statistical |
1 |
|
naprosyn |
1 |
|
naproxen |
1 |
|
nurse practitioners |
1 |
|
personnel, hospital |
1 |
|
physicians, family |
1 |
|
referral rates |
1 |
|
respiration disorders - economics - therapy |
1 |
|
rotavirus |
1 |
|
rotavirus vaccine |
1 |
|
sensitivity analysis |
1 |
|
sensitivity and specificity |
1 |
|
severe acute respiratory syndrome - epidemiology - etiology - prevention & control |
1 |
|
specialist |
1 |
|
thailand - epidemiology |
1 |
|
therapy, computer-assisted |
1 |
|
treatment outcome |
1 |
|
treatment patterns |
1 |
|
world health |
1 |
